These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 6852720

  • 1. [Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors].
    Maier U, Kuber W.
    Fortschr Med; 1983 Mar 31; 101(12):535-40. PubMed ID: 6852720
    [Abstract] [Full Text] [Related]

  • 2. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
    Flamm J, Grof F.
    Urologe A; 1985 Jan 31; 24(1):31-5. PubMed ID: 4039083
    [Abstract] [Full Text] [Related]

  • 3. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group].
    Aikawa K, Irisawa C, Muraki O, Yamaguchi O, Shiraiwa Y, Noguchi M, Koguchi M, Yokoyama J, Ito K, Kumakawa K.
    Gan To Kagaku Ryoho; 1992 Apr 31; 19(4):509-13. PubMed ID: 1558401
    [Abstract] [Full Text] [Related]

  • 4. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H, Yokota K, Kurokawa Y, Kagawa S, Yokozeki H, Inai T, Ogawa I, Akazawa S, Hashimoto H, Mizuta K.
    Gan To Kagaku Ryoho; 1999 Apr 31; 26(5):651-5. PubMed ID: 10234296
    [Abstract] [Full Text] [Related]

  • 5. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B, el-Baz M, Aly AN, Shamaa S, Ashamallah A.
    J Urol; 1997 Jul 31; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [Abstract] [Full Text] [Related]

  • 6. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H, Kuroiwa K, Yamaguchi A, Osada Y, Tsuneyoshi M, Naito S.
    J Urol; 2004 Jan 31; 171(1):153-7. PubMed ID: 14665865
    [Abstract] [Full Text] [Related]

  • 7. [Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence].
    Hashimoto H, Yachiku S, Watabe Y, Niibori D, Yamauchi K, Osanai H, Ohashi K, Wakabayashi A, Fujisawa M.
    Gan To Kagaku Ryoho; 1994 May 31; 21(6):833-8. PubMed ID: 8185341
    [Abstract] [Full Text] [Related]

  • 8. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer].
    Miki T, Nonomura N, Kojima Y, Okuyama A, Nakano E, Kiyohara H, Fujioka H, Koide T, Wakatsuki A, Kuroda H, Sugao H, Seguti T, Takeyama M, Yamaguchi S.
    Hinyokika Kiyo; 1997 Dec 31; 43(12):907-12. PubMed ID: 9488944
    [Abstract] [Full Text] [Related]

  • 9. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
    Kuroda K, Ishii N, Fukasawa K, Shirai M, Tajima M, Matsushima M, Miura K, Takanami M, Matsuhashi M, Kuwabara T, Matsumoto H, Sugita M.
    Hinyokika Kiyo; 1998 Aug 31; 44(8):547-52. PubMed ID: 9783189
    [Abstract] [Full Text] [Related]

  • 10. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
    Hinotsu S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, Obata K, Ohashi Y, Ohe H, Shimazaki J, Tashiro K, Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin.
    Gan To Kagaku Ryoho; 2002 Jan 31; 29(1):73-80. PubMed ID: 11816482
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
    Engeler DS, Wyler S, Neyer M, Hobi C, Müller J, Schmid HP.
    Scand J Urol Nephrol; 2008 Jan 31; 42(6):522-7. PubMed ID: 18609290
    [Abstract] [Full Text] [Related]

  • 12. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
    Mitsumori K, Tsuchiya N, Habuchi T, Li Z, Akao T, Ohyama C, Sato K, Kato T.
    BJU Int; 2004 Aug 31; 94(3):317-21. PubMed ID: 15291859
    [Abstract] [Full Text] [Related]

  • 13. [Prevention of recurrence in non-invasive bladder carcinoma. Experiences with 400 patients].
    Burk K, Troller RM, Pittner P.
    Urologe A; 1983 Sep 31; 22 Suppl():332-6. PubMed ID: 6356556
    [Abstract] [Full Text] [Related]

  • 14. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 31; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 15. [Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ].
    Shichiri Y, Kanba T, Yoshida S, Arai Y.
    Hinyokika Kiyo; 1995 May 31; 41(5):359-64. PubMed ID: 7598036
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer.
    Okamura T, Tozawa K, Yamada Y, Sakagami H, Ueda K, Kohri K.
    J Urol; 1996 Sep 31; 156(3):967-71. PubMed ID: 8709375
    [Abstract] [Full Text] [Related]

  • 17. [Long-term results and complications of intravesical instillation of bacillus Calmette-Guerin for prophylaxis of bladder cancer recurrence].
    Irie A, Lee KE, Kadowaki K, Sawamura M.
    Hinyokika Kiyo; 1994 Oct 31; 40(10):873-7. PubMed ID: 7992700
    [Abstract] [Full Text] [Related]

  • 18. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.
    Berrum-Svennung I, Granfors T, Jahnson S, Boman H, Holmäng S.
    J Urol; 2008 Jan 31; 179(1):101-5; discussion 105-6. PubMed ID: 17997459
    [Abstract] [Full Text] [Related]

  • 19. [Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer].
    Segawa N, Inamoto T, Nomi H, Ibuki N, Azuma H, Katsuoka Y.
    Hinyokika Kiyo; 2009 Apr 31; 55(4):175-80. PubMed ID: 19462820
    [Abstract] [Full Text] [Related]

  • 20. [Serum uptake of doxorubicin intravesically administered soon after transurethral resection of bladder carcinoma].
    Nagakura K, Takao M, Odajima K, Ieda K, Fujioka T, Hayakawa M, Murai M, Nakamura H.
    Hinyokika Kiyo; 1989 Sep 31; 35(9):1509-12. PubMed ID: 2816617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.